Pharmacotherapy for Obesity
For individuals struggling with weight loss despite diet, exercise, and lifestyle changes, medical therapy offers a scientifically backed, effective alternative. Modern pharmacological treatments target the biology of appetite and metabolism, helping patients achieve sustainable weight loss and improve metabolic health.
Who is a Candidate for Obesity Medications?
Pharmacotherapy is recommended for individuals who:
- Have a BMI ≥30 kg/m², or
- Have a BMI ≥27 kg/m² with obesity-related health issues such as type 2 diabetes, PCOS, fatty liver, hypertension, or sleep apnea.
Semaglutide (GLP-1 Receptor Agonist)
Semaglutide is a once-weekly injectable medication or a daily oral tablet originally used for diabetes but now FDA-approved for weight loss.
Semaglutide mimics GLP-1, a natural gut hormone that:
- Reduces appetite
- Delays gastric emptying
- Improves insulin sensitivity
Clinical studies show up to 15% total body weight loss with semaglutide when combined with lifestyle changes.
Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
Tirzepatide is a weekly injectable that targets two gut hormones – GIP and GLP-1 – for enhanced metabolic effect.
- Suppresses hunger and increases satiety
- Enhances insulin action
- Promotes fat loss while preserving muscle mass
Tirzepatide has shown up to 20% total body weight loss in some studies, making it one of the most powerful anti-obesity drugs available today.
Is Medical Weight Loss Right for You?
These medications are not a shortcut, but a valuable tool for patients who:
- Have struggled with traditional weight loss methods
- Need to reduce weight in order to qualify for Bariatric surgery
- Are looking to improve long-term health outcomes
A thorough medical evaluation is necessary to determine the right treatment, rule out contraindications, and design a personalized plan.
Ready to take control of your weight?
Book a consultation to explore whether medical weight loss therapy, including semaglutide or tirzepatide, is right for you.
